IllumiNeuro Blend 48mg – PE-22-28 10mg + Pinealon 10mg + N-Acetyl Semax 20mg + N-Acetyl Selank 8mg
Original price was: € 159,00.€ 119,00Current price is: € 119,00.
To make room for a newly tested batch, products from the previous batch are temporarily reduced.
Same verified quality — price returns to normal once sold out.
IllumiNeuro Blend 48 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms precise assay content of N-Acetyl Selank 7.14 mg, N-Acetyl Semax 19.8 mg, PE-22-28 12.34 mg and Pinealon 12.00 mg, with endotoxin levels below 0.001 EU/mg.
No detectable levels of heavy metals including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium.
Supplied as a 48 mg lyophilized multi-peptide blend with full COA traceability.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
For research use only — not for human or veterinary use.
Analytical Verification (COA)
Each batch of IllumiNeuro Blend supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.
Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.
Batch: GF-ILLU48-B242
Key analytical results include:
- N-Acetyl Selank Assay: 7.14 mg
- N-Acetyl Semax Assay: 19.8 mg
- PE-22-28 Assay: 12.34 mg
- Pinealon Assay: 12.00 mg
- Identification – Retention Time: 0.989 – 0.998
- Bacterial Endotoxins: below 0.001 EU per mg
- Total Aerobic Microbial Count: not detected
- Total Yeast and Mold Count: not detected
Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.
These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency. :contentReference[oaicite:0]{index=0}
Product Overview
IllumiNeuro Blend is a multi-peptide formulation designed for controlled laboratory research involving peptide signalling pathways and neurochemical interaction models.
The combination of N-Acetyl Semax, N-Acetyl Selank, PE-22-28 and Pinealon allows for advanced experimental study of peptide synergy and signalling dynamics.
This preparation contains a total of 48 mg of high purity lyophilized peptides supplied in a sealed research vial. The lyophilization process preserves stability and enables precise reconstitution for in vitro experimentation.
Due to its defined multi-compound structure, this blend is frequently referenced in advanced peptide research models.
Compound Overview
IllumiNeuro Blend combines multiple synthetic peptides studied for their interaction with signalling pathways and molecular regulatory systems.
Within experimental models, the combination is commonly investigated for its interaction with peptide-mediated signalling networks and receptor dynamics.
Because of its defined composition, the blend is frequently used in laboratory studies examining peptide synergy and interaction effects.
Historical Background and Scientific Context
Scientific interest in multi-peptide formulations has expanded with advances in molecular biology and neurochemical research.
Blended peptide systems have been developed to explore interaction effects between signalling pathways in controlled environments.
This has enabled deeper investigation into complex peptide-mediated biological mechanisms.
Mechanistic Focus in Research
Within experimental laboratory settings, IllumiNeuro Blend is commonly studied in relation to peptide signalling interactions.
Research investigations commonly explore the compound in experimental models examining:
- Peptide signalling pathways
- Neurochemical interaction models
- Multi-peptide synergy
- Receptor interaction dynamics
- Intracellular signalling mechanisms
- Comparative peptide research
- Molecular pathway analysis
These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.
Research Applications
In controlled research environments, IllumiNeuro Blend may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions.
Examples of research applications include:
- Multi-peptide signalling research
- Receptor interaction studies
- Neurochemical modelling
- Comparative peptide studies
- Molecular pathway analysis
- Controlled in vitro research
- Laboratory signalling studies
Grail Formula Quality
Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.
Each batch undergoes independent analytical testing to verify:
- Compound identity
- Assay accuracy
- Purity confirmation
- Microbial safety
- Endotoxin levels
- Heavy metal screening
- Full batch traceability
All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.
Research Use Limitation
- Used solely for in vitro experiments
- Not permitted for clinical trials involving humans
- Not permitted for human or veterinary administration
- Not permitted for investigational human use
- Independently analysed by Liquilabs s.r.o. Czechia
- Multi-peptide assay verification per compound
- N-Acetyl Semax 19.8 mg and PE-22-28 12.34 mg confirmed
- N-Acetyl Selank 7.14 mg and Pinealon 12.00 mg confirmed
- Endotoxin level below 0.001 EU/mg
- No detectable heavy metals or microbial contamination
- Advanced multi-peptide blend for controlled laboratory research
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
